1. Home
  2. MVBF vs EIKN Comparison

MVBF vs EIKN Comparison

Compare MVBF & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

N/A

Current Price

$23.01

Market Cap

335.2M

Sector

Finance

ML Signal

N/A

Logo Eikon Therapeutics Inc. Common Stock

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$4.80

Market Cap

316.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MVBF
EIKN
Founded
1997
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.2M
316.3M
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
MVBF
EIKN
Price
$23.01
$4.80
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
★ $30.50
$24.00
AVG Volume (30 Days)
65.8K
★ 511.7K
Earning Date
10-29-2026
11-12-2026
Dividend Yield
★ 2.91%
N/A
EPS Growth
N/A
N/A
EPS
★ 1.35
N/A
Revenue
★ $3,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.88
N/A
P/E Ratio
$17.30
★ N/A
Revenue Growth
★ 51.92
N/A
52 Week Low
$23.01
$4.72
52 Week High
$31.99
$16.50

Technical Indicators

Market Signals
Indicator
MVBF
EIKN
Relative Strength Index (RSI) 21.24 33.10
Support Level N/A N/A
Resistance Level $26.60 $6.82
Average True Range (ATR) 0.88 0.63
MACD -0.20 -0.04
Stochastic Oscillator 3.26 3.10

Price Performance

Historical Comparison
MVBF
EIKN

About MVBF MVB Financial Corp.

MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About EIKN Eikon Therapeutics Inc. Common Stock

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Share on Social Networks: